Filter
537
Text search:
Medicines
for
opportunistic
infections
Featured
Recommendations
63
New Publications
189
Language
Document type
No document type
373
Guidelines
74
Studies & Reports
42
Manuals
14
Training Material
12
Strategic & Response Plan
6
Situation Updates
5
Fact sheets
5
Infographics
4
Brochures
1
Online Courses
1
Countries / Regions
India
36
Kenya
26
Tanzania
24
Ethiopia
18
Malawi
17
Zambia
13
South Africa
13
Zimbabwe
12
Namibia
12
Uganda
11
Nepal
11
Liberia
9
Ghana
9
Rwanda
9
Lesotho
9
Global
8
Sierra Leone
7
Ukraine
7
Myanmar / Burma
6
Africa
6
Cambodia
5
Bangladesh
5
Latin America and the Carribbean
5
Nigeria
4
Venezuela
4
Russia
4
Pakistan
3
Mozambique
3
Eswatini/ Swaziland
3
Asia
3
Eastern Europe
3
Albania
3
Burkina Faso
2
Congo, Democratic Republic of
2
Indonesia
2
Botswana
2
East and Southern Africa
2
Georgia
2
Guinea
1
Cameroon
1
Haiti
1
Philippines
1
Afghanistan
1
Syria
1
Gambia
1
Benin
1
Central African Republic
1
Argentina
1
Peru
1
Brazil
1
Colombia
1
Bolivia
1
Sri Lanka
1
Chile
1
West and Central Africa
1
Middle East and North Africa
1
South–East Asia Region
1
Western and Central Europe
1
Bhutan
1
Southern Africa
1
Iran
1
North America
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
249
Clinical Guidelines
46
Capacity Building
22
Women & Child Health
21
Public Health
20
Key Resources
7
Pharmacy & Technologies
2
Toolboxes
HIV
149
TB
43
AMR
23
Pharmacy
18
Caregiver
9
Refugee
7
Conflict
6
COVID-19
6
Mental Health
4
NTDs
4
NCDs
4
Disability
3
Ebola & Marburg
2
Health Financing Toolbox
2
Malaria
2
Global Health Education
1
Follow up to the Maseru Declaration. ZIMBABWE COUNTRY REPORT
Reporting Period: January 2013 - December 2013
Joint United Nations Programme on HIV/AIDS (UNAIDS).
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Essential Drug list on page 36!!
The COVID-19 pandemic has exposed the inadequacy of investments in public health, the persistence of profound economic and social inequalities and the fragility of many key global systems and approaches.
A global Review of evidence and practice
HIV/TB workplace policy and Implementation Strategy
1-13 December 2018 | Geneva, Switzerland UNAIDS Programme Coordinating Board Issue date: 23 November 2018
UNAIDS/PCB (43)/18.32